Sergio Fazio, MD, PhD

Professor of Medicine and Pathology
Co-Director, Lipid Clinic and Atherosclerosis Research Unit
Director, Lipid Laboratory
Vanderbilt University Medical Center
Nashville, Tennessee

Sergio Fazio, MD, PhD is professor of medicine and pathology at Vanderbilt University in Nashville, Tennessee. He also is the co-director of the Lipid Clinic and Atherosclerosis Research Unit, and director of the Lipid Laboratory.

Dr. Fazio is a graduate of the medical school of the University of Rome, Italy, and completed his internship and residency in internal medicine. Dr. Fazio also earned a doctorate of philosophy in experimental medicine from the University of Siena in Italy. After a clinical fellowship in metabolism at the University of Rome, and a research fellowship at the Cardiovascular Research Institute, University of California, San Francisco, he was promoted to instructor in medicine at the University of California at San Francisco before joining the medical faculty at Vanderbilt University.

Dr. Fazio has served on review panels for and received grants from both the National Institutes of Health and the American Heart Association, as well as industry support for clinical trials. He also regularly serves as ad hoc reviewer for many scientific publications and is an editorial board member for Arteriosclerosis, Thrombosis, Vascular Biology, and The Journal of Clinical Endocrinology and Metabolism. As author or co-author, Dr. Fazio’s work has been published in many leading journals, including Science, Journal of Clinical Investigation, Circulation, and Nature Medicine.

His current research interests include the pathogenesis of plasma lipoprotein alterations and the mechanisms of early atherogenesis.